{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T19:09:39Z","timestamp":1776539379233,"version":"3.51.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T00:00:00Z","timestamp":1234915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1477-7525-7-13","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T07:14:23Z","timestamp":1236064463000},"source":"Crossref","is-referenced-by-count":24,"title":["Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo"],"prefix":"10.1186","volume":"7","author":[{"given":"Philip EV","family":"Van Kerrebroeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Con J","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin S","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph T","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,18]]},"reference":[{"key":"530_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/nau.20251","volume":"25","author":"P Abrams","year":"2006","unstructured":"Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P: Reviewing the ICS 2002 Terminology Report: The Ongoing Debate. Neurourol Urodyn 2006, 25: 293. 10.1002\/nau.20251","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"530_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A: The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003,61(1):37\u201349. 10.1016\/S0090-4295(02)02243-4","journal-title":"Urology"},{"issue":"6","key":"530_CR3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ: Prevalence and burden of overactive bladder in the United States. World J Urol 2003,20(6):327\u2013336.","journal-title":"World J Urol"},{"issue":"9","key":"530_CR4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","volume":"87","author":"I Milsom","year":"2001","unstructured":"Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001,87(9):760\u2013766. 10.1046\/j.1464-410x.2001.02228.x","journal-title":"BJU Int"},{"key":"530_CR5","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne KS, Kelleher C, Hampel C, Artibani W, et al.: Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 2006, 50: 1306\u20131315. 10.1016\/j.eururo.2006.09.019","journal-title":"Eur Urol"},{"issue":"1","key":"530_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1474-4422(03)00622-7","volume":"3","author":"KE Andersson","year":"2004","unstructured":"Andersson KE: Antimuscarinics for the treatment of overactive bladder. Lancet Neurol 2004,3(1):46\u201353. 10.1016\/S1474-4422(03)00622-7","journal-title":"Lancet Neurol"},{"key":"530_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1524-4733.1999.02210.x","volume":"2","author":"NK Leidy","year":"1999","unstructured":"Leidy NK, Revicki DA, Geneste B: Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999, 2: 113\u2013127. 10.1046\/j.1524-4733.1999.02210.x","journal-title":"Value Health"},{"issue":"4","key":"530_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1023\/A:1023422208910","volume":"12","author":"PR Reese","year":"2003","unstructured":"Reese PR, Pleil AM, Okano GJ, Kelleher CJ: Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder. Qual Life Res 2003,12(4):427\u2013442. 10.1023\/A:1023422208910","journal-title":"Qual Life Res"},{"issue":"6","key":"530_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","volume":"49","author":"KS Coyne","year":"2006","unstructured":"Coyne KS, Matza LS, Kopp Z, Abrams P: The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol 2006,49(6):1079\u20131086. 10.1016\/j.eururo.2006.01.007","journal-title":"Eur Urol"},{"issue":"6","key":"530_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1023\/A:1016370925601","volume":"11","author":"K Coyne","year":"2002","unstructured":"Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, Kurth H, Abrams P: Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 2002,11(6):563\u2013574. 10.1023\/A:1016370925601","journal-title":"Qual Life Res"},{"issue":"6","key":"530_CR11","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S0090-4295(01)00986-4","volume":"57","author":"JN Liberman","year":"2001","unstructured":"Liberman JN, Hunt TL, Stewart WF, Wein A, Zhou Z, Herzog AR, Lipton RB, Diokno AC: Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology 2001,57(6):1044\u20131050. 10.1016\/S0090-4295(01)00986-4","journal-title":"Urology"},{"issue":"4","key":"530_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1524-4733.2004.74008.x","volume":"7","author":"KS Coyne","year":"2004","unstructured":"Coyne KS, Payne C, Bhattacharyya SK, Revicki DA, Thompson C, Corey R, Hunt TL: The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health 2004,7(4):455\u2013463. 10.1111\/j.1524-4733.2004.74008.x","journal-title":"Value Health"},{"issue":"7","key":"530_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1046\/j.1464-410X.2003.04463.x","volume":"92","author":"KS Coyne","year":"2003","unstructured":"Coyne KS, Zhou Z, Thompson C, Versi E: The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int 2003,92(7):731\u2013735. 10.1046\/j.1464-410X.2003.04463.x","journal-title":"BJU Int"},{"key":"530_CR14","first-page":"S580","volume":"6","author":"P Abrams","year":"2000","unstructured":"Abrams P, Kelleher C, Lerr L, Rogers R: Overactive bladder significantly affects quality of life. Am J Manag Care 2000, 6: S580\u2013590.","journal-title":"Am J Manag Care"},{"issue":"1","key":"530_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1464-410X.2005.05889.x","volume":"97","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L: Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int 2006,97(1):96\u2013100. 10.1111\/j.1464-410X.2005.05889.x","journal-title":"BJU Int"},{"issue":"19 Suppl","key":"530_CR16","first-page":"S608","volume":"8","author":"CJ Kelleher","year":"2002","unstructured":"Kelleher CJ, Reese PR, Pleil AM, Okano GJ: Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care 2002,8(19 Suppl):S608-S615.","journal-title":"Am J Manag Care"},{"issue":"4","key":"530_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00345-004-0455-3","volume":"22","author":"Y Homma","year":"2004","unstructured":"Homma Y, Kawabe K: Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial. World J Urol 2004,22(4):251\u2013256. 10.1007\/s00345-004-0455-3","journal-title":"World J Urol"},{"issue":"3","key":"530_CR18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0029-7844(03)00623-9","volume":"102","author":"R Freeman","year":"2003","unstructured":"Freeman R, Hill S, Millard R, Slack M, Sutherst J: Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine. Obstet Gynecol 2003,102(3):605\u2013611. 10.1016\/S0029-7844(03)00623-9","journal-title":"Obstet Gynecol"},{"key":"530_CR19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1742-1241.2006.00987.x","volume":"60","author":"R Roberts","year":"2006","unstructured":"Roberts R, Bavendam T, Glasser DB, Carlsson M, Eyland N, Elinoff V: Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial. Int J Clin Pract 2006, 60: 752\u2013758. 10.1111\/j.1742-1241.2006.00987.x","journal-title":"Int J Clin Pract"},{"issue":"suppl 2A","key":"530_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.urology.2006.05.044","volume":"68","author":"P Abrams","year":"2006","unstructured":"Abrams P, Artibani W, Gajewski JB, Hussain I: Assessment of treatment outcomes in patients with overactive bladder: importance of objective and subjective measures. Urology 2006,68(suppl 2A):17\u201328. 10.1016\/j.urology.2006.05.044","journal-title":"Urology"},{"issue":"3","key":"530_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","volume":"57","author":"P van Kerrebroeck","year":"2001","unstructured":"van Kerrebroeck P, Kreder K, Jonas U, Zinner N, Wein A: Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology 2001,57(3):414\u2013421. 10.1016\/S0090-4295(00)01113-4","journal-title":"Urology"},{"issue":"12","key":"530_CR22","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","volume":"104","author":"CJ Kelleher","year":"1997","unstructured":"Kelleher CJ, Cardozo LD, Khullar V, Salvatore S: A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997,104(12):1374\u20131379.","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"530_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1471-0528.2004.00129.x","volume":"111","author":"CJ Kelleher","year":"2004","unstructured":"Kelleher CJ, Pleil AM, Reese PR, Burgess SM, Brodish PH: How much is enough and who says so? The case of the King's Health Questionnaire and overactive bladder. BJOG 2004,111(6):605\u2013612. 10.1111\/j.1471-0528.2004.00129.x","journal-title":"BJOG"},{"key":"530_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/nau.20110","volume":"24","author":"LS Matza","year":"2005","unstructured":"Matza LS, Thompson CL, Krasnow J, Brewster-Jordan J, Zycyzynski T, Coyne KS: Test-retest reliability of four questionnaires for patients with overactive bladder: the Overactive Bladder Questionnaire (OAB-q), Patient Perception of Bladder Condition (PPBC), Urgency Questionnaire (UQ), and the Primary OAB Symptom Questionnaire (POSQ). Neurourol Urodyn 2005, 24: 215\u2013225. 10.1002\/nau.20110","journal-title":"Neurourol Urodyn"},{"key":"530_CR25","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J: Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.","edition":"2"},{"issue":"7","key":"530_CR26","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1046\/j.1464-410X.2003.04468.x","volume":"92","author":"Y Homma","year":"2003","unstructured":"Homma Y, Paick JS, Lee JG, Kawabe K: Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial. BJU Int 2003,92(7):741\u2013747. 10.1046\/j.1464-410X.2003.04468.x","journal-title":"BJU Int"},{"issue":"1","key":"530_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.eururo.2004.11.012","volume":"48","author":"MC Michel","year":"2005","unstructured":"Michel MC, de la Rosette JJ, Piro M, Schneider T: Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder. Eur Urol 2005,48(1):110\u2013115. 10.1016\/j.eururo.2004.11.012","journal-title":"Eur Urol"},{"issue":"6","key":"530_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1742-1241.2008.01778.x","volume":"62","author":"KS Coyne","year":"2008","unstructured":"Coyne KS, Elinoff V, Gordon DA, Deng DY, Brodsky M, Glasser DB, Jumadilova Z, Carlsson M: Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine. Int J Clin Pract 2008,62(6):925\u2013931. 10.1111\/j.1742-1241.2008.01778.x","journal-title":"Int J Clin Pract"},{"key":"530_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s11136-004-0706-1","volume":"14","author":"KS Coyne","year":"2005","unstructured":"Coyne KS, Matza LS, Thompson CL: The responsiveness of the Overactive Bladder Questionnaire (OAB-q). Qual Life Res 2005, 14: 849\u2013855. 10.1007\/s11136-004-0706-1","journal-title":"Qual Life Res"},{"issue":"suppl 2A","key":"530_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.urology.2006.05.042","volume":"68","author":"K Coyne","year":"2006","unstructured":"Coyne K, Tubaro A, Brubaker L, Bavendam T: Development and validation of patient-reported outcomes measures for overactive bladder. Urology 2006,68(suppl 2A):9\u201316. 10.1016\/j.urology.2006.05.042","journal-title":"Urology"},{"issue":"2","key":"530_CR31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","volume":"68","author":"Y Homma","year":"2006","unstructured":"Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O: Symptom assessment tool for overactive bladder syndrome \u2013 overactive bladder symptom score. Urology 2006,68(2):318\u2013323. 10.1016\/j.urology.2006.02.042","journal-title":"Urology"},{"key":"530_CR32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1464-410X.2005.05345.x","volume":"95","author":"L Cardozo","year":"2005","unstructured":"Cardozo L, Coyne KS, Versi E: Validation of the Urgency Perception Scale. BJU Int 2005, 95: 591\u2013596. 10.1111\/j.1464-410X.2005.05345.x","journal-title":"BJU Int"},{"issue":"suppl 2A","key":"530_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.urology.2006.02.046","volume":"68","author":"D Marschall-Kehrel","year":"2006","unstructured":"Marschall-Kehrel D, Roberts RG, Brubaker L: Patient-reported outcomes in overactive bladder: the influence of perception of condition and expectation for treatment benefit. Urology 2006,68(suppl 2A):29\u201337. 10.1016\/j.urology.2006.02.046","journal-title":"Urology"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7525-7-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-7525-7-13\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7525-7-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T07:57:35Z","timestamp":1589615855000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/1477-7525-7-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,18]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["530"],"URL":"https:\/\/doi.org\/10.1186\/1477-7525-7-13","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,18]]},"article-number":"13"}}